AbCellera Biologics Inc. (ABCL)

Last Closing Price: 11.02 (2026-11-18)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

AbCellera Biologics Inc. (ABCL) had Revenue of $10.64M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
Revenue
$10.64M
$-40.76M
--
$10.64M
$63.95M
$-53.31M
$10.50M
$-42.81M
$-42.81M
$-40.76M
$-40.76M
$-40.76M
$-40.76M
$-53.31M
$-44.70M
318.05M
318.05M
$-0.13
$-0.13
Balance Sheet Financials
$876.16M
$410.05M
$623.71M
$1.50B
$70.47M
--
$366.89M
$437.36M
$1.06B
$976.30M
$1.06B
326.33M
Cash Flow Statement Financials
$19.31M
$-197.18M
$214.22M
$155.25M
$190.76M
$35.51M
$35.97M
--
--
Fundamental Metrics & Ratios
12.43
--
--
--
--
100.00%
-501.13%
-501.13%
--
-402.41%
-383.10%
$11.74M
--
--
--
0.01
--
0.59
151.97
-3.84%
-4.17%
-2.72%
-3.84%
$3.26
$0.04
$0.06